Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Bone marrow mononuclear cells

ABSTRACT: Bone marrow mononuclear cells

PROVIDER: PRJNA801122 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR17779359.fastq.gz	Fastqsanger.gz
	SRR17779360.fastq.gz	Fastqsanger.gz
	SRR17779275_1.fastq.gz	Fastqsanger.gz
	SRR17779275_2.fastq.gz	Fastqsanger.gz
	SRR17779276_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 14

Similar Datasets

Single cell RNA sequencing of bone marrow mononuclear cells

Project description:Bone marrow aspirates were obtained from patients with relapsed/refractory large B cell lymphoma (rrLBCL), mononuclear cells isolated by ficoll density-gradient centrifugation, and loaded onto a 10X Chromium for single cell RNA-sequencing using 5Ã¢Â€Â™ chemistry without prior cryopreservation. Healthy donor bone marrow mononuclear cells were obtained from healthy allogeneic stem cell transplant donors and analyzed following viable cryopreservation.

| EGAS00001006836 | EGA

RNA-sequencing of pediatric acute lymphoblastic leukemia bone marrow mononuclear cells

Project description:RNA-sequencing of pediatric acute lymphoblastic leukemia bone marrow mononuclear cells

| PRJNA950892 | ENA

Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

Project description:RATIONALE: Radiation therapy uses high-energy x-rays to damage cancer cells. Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining chemotherapy with bone marrow transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of bone marrow transplantation in treating patients who have hematologic cancer.

| 2004880 | ecrin-mdr-crc

RNA-seq of CD11bhiLy6ChiLy6Glo bone marrow cells and CD11bmidLy6CmidLy6Glo bone marrow cells against CD11bloLy6CloLy6Glo bone marrow cells

Project description:RNA-seq of CD11bhiLy6ChiLy6Glo bone marrow cells and CD11bmidLy6CmidLy6Glo bone marrow cells against CD11bloLy6CloLy6Glo bone marrow cells

| PRJEB37925 | ENA

Single cell RNA-seq for bone marrow mononuclear cells from CAR-T therapy received DLBCL patient

Project description:To investigate whether metoprolol treatment could affect immune cells population and proinflammatory gene expression in bone marrow mononuclear cells from CAR-T therapy received DLBCL patient

2023-07-31 | GSE195525 | GEO

RNA-seq of of bone marrow derived mononuclear phagocytes

Project description:RNA-seq of of bone marrow derived mononuclear phagocytes

| PRJEB26391 | ENA

Gene expression profile at single cell level of AS-like Macaca fascicularis bone marrow mononuclear cell

Project description:Ankylosing Spondylitis (AS) like and control macaca fascicularis bone marrow mononuclear cell, mainly immune cells.

2025-06-01 | GSE268839 | GEO

Comparative Single Cell RNA Sequencing of Notch2 and RBPJ-deficient mononuclear phagocyte cells and myeloid progenitors from the spleen and bone marrow

Project description:Mononuclear phagocytes and their myeloid progenitors are critical in various homeostatic processes as well as immune responses. We employed single-cell RNA sequencing to investigate myeloid progenitors and mononuclear phagocytic cell subsets, including monocytes, splenic red pulp macrophages and dendritic cells in the spleen and in the bone marrow, with a focus on how Notch2 and its nuclear mediator Rbpj regulate these subsets. Our study offers a comparative analysis of mononuclear phagocytes and their progenitors examining cells isolated from the spleens or bone marrow of myeloid Notch2 (N2ΔCx3cr1)-, and Rbpj (RbpjΔCx3cr1)-deficient mice or control animals. Our findings may provide further insights into the heterogeneity of the mononuclear phagocytic cells in the spleen and bone marrow and show the critical role of Notch signaling in their development.

2025-10-30 | GSE289018 | GEO

Haploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancer

Project description:This phase II trial studies how well giving fludarabine phosphate, cyclophosphamide, tacrolimus, mycophenolate mofetil and total-body irradiation together with a donor bone marrow transplant works in treating patients with high-risk hematologic cancer. Giving low doses of chemotherapy, such as fludarabine phosphate and cyclophosphamide, and total-body irradiation before a donor bone marrow transplant helps stop the growth of cancer cells by stopping them from dividing or killing them. Giving cyclophosphamide after transplant may also stop the patient’s immune system from rejecting the donor’s bone marrow stem cells. The donated stem cells may replace the patient’s immune system cells and help destroy any remaining cancer cells (graft-versus-tumor effect). Sometimes the transplanted cells from a donor can also make an immune response against the body’s normal cells. Giving tacrolimus and mycophenolate mofetil after the transplant may stop this from happening

| 2008483 | ecrin-mdr-crc

Characteristics between porcine bone marrow-derived mesenchymal stem and peripheral blood mononuclear cells

Project description:Characteristics between porcine bone marrow-derived mesenchymal stem and peripheral blood mononuclear cells

| PRJNA1197383 | ENA